The new ULLA-based European Training Network COLOTAN is recruiting 13 early stage researchers (ESRs).
COLOTAN is a network for Boosting advanced doctoral training in innovative colon targeting drugs. Its overarching goal is to provide high-level training to 13 ESRs in drug delivery, drug disposition and gastrointestinal (GI) (patho)physiology to improve targeting of drugs to the colon and to provide the ESRs with the transferable and scientific skills necessary for a successful career. This international training program, combining 10 countries, focuses on innovative technological and scientific developments across a range of interdisciplinary fields such as physical, analytical and organic chemistry, drug delivery, drug disposition, cell biology, gastroenterology, microbiology, and modelling and simulation. The aim of this project will be achieved by a unique combination of intersectoral research training facilitated by 10 beneficiaries (7 academic and 3 non-academic) and 6 partner organisations. The COLOTAN consortium consists of leading research groups from universities and from innovative pharmaceutical companies.
Each of the 13 ESRs will be working towards a PhD degree, supported by a carefully chosen supervisory team that maximizes both scientific excellence as well as interdisciplinary and intersectoral collaboration. The 13 COLOTAN ESRs will not only receive state-of-the-art science/technology training but will also benefit from a unique soft-skills training programme. The interdisciplinary and inter-domain training will make COLOTAN ESRs highly employable in various industries or academia.
Application deadline: 1 December 2020.
More information and on-line application: https://colotan-etn.eu.